Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation

Vaccine

Volumn 26, Issue 34, 2008, Pages 4352-4362

  Sarkar, Koustav ^a   Bose, Anamika ^a   Chakraborty, Krishnendu ^a   Haque, Enamul ^a   Ghosh, Diptendu ^a   Goswami, Shyamal ^a   Chakraborty, Tathagata ^a   Laskar, Subrata ^b   Baral, Rathindranath ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b UNIVERSITY OF BURDWAN   (India)

Author keywords

Carcinoembryonic antigen; Macrophages; Neem leaf glycoprotein

Indexed keywords

CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; CD11B ANTIGEN; CD19 ANTIGEN; IMMUNOGLOBULIN G2A ANTIBODY; NEEM LEAF GLYCOPROTEIN; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; AZADIRACHTA INDICA; B LYMPHOCYTE ACTIVATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO SELECTION; IN VIVO STUDY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEOPLASM; ANTIGEN PRESENTATION; AZADIRACHTA; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; CELL SURVIVAL; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GLYCOPROTEINS; MACROPHAGES; MICE; NEOPLASMS; PLANT LEAVES; PLANT PROTEINS; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 47849092860     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.06.048     Document Type: Article

References (44)

1. Foon K.A., John W.J., Chakraborty M., Das R., Teitelbaum A., Garrison J., et al. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. J Clin Oncol 17 9 (1999) 2889-2895
2. Baral R., Mandal I., and Chattopadhyay U. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine. Int Immunopharmacol 5 7-8 (2005) 343-352
3. Stevanovic S. Identification of tumor associated T-cell epitopes for vaccine development. Nat Rev Cancer 2 7 (2002) 514-520
4. Astsaturov I., Petrella T., Bagriacik E., de Benedette M., Uger R., Lumber G., et al. Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha2b: implications for cancer vaccines. Clin Cancer Res 9 12 (2003) 4347-4355
5. Baral R.N. Tumor vaccine: current trends in antigen specific immunotherapy (review). Ind J Exp Biol 43 5 (2005) 389-406
6. Germain R.N., and Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Ann Rev Immunol 11 (1993) 403-450
7. Unanue E.R., and Allen P.M. Biochemistry and biology of antigen presentation by macrophages. Cell Immunol 99 1 (1986) 3-6
8. Underhill D.M., Bassetti M., Rudensky A., and Aderem A. Dynamic interactions of macrophages with T cells during antigen presentation. J Exp Med 190 12 (1999) 1909-1914
9. Kosco M.H. Antigen presentation to B cells. Curr Opin Immunol 3 3 (1991) 336-339
10. Adams D.O., and Hamilton T.A. The cell biology of macrophage activation. Ann Rev Immunol 2 (1984) 283-318
11. Brewer J.M., Richmond J., and Alexander J. The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies. Clin Exp Immunol 97 1 (1994) 164-171
12. Keller R. The macrophage response to infectious agents: mechanisms of macrophage activation and tumor cell killing. Res Immunol 144 4 (1993) 271-273
13. Van Rooijen N. Macrophages as accessory cells in the in vivo humoral immune response: from processing of particular antigens to regulation by suppression. Semin Immunol 4 4 (1992) 237-245
14. Van Rooijen N., Wijburg O.L.C., Van den Dobbelsteen G.P.J.M., and Sanders A. Macrophages in host defense mechanisms. Curr Top Microbiol Immunol 210 (1996) 159-165
15. Morrissette N., Gold E., and Aderem A. The macrophage-a cell for all seasons. Trends Cell Biol 9 5 (1999) 199-201
16. Mandal-Ghosh I., Chattopadhyay U., and Baral R. Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen. Cancer Immun 7 (2007) 8-17
17. Chakraborty K., Bose A., Pal S., Sarkar K., Goswami S., Ghosh D., et al. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance. Int Immunopharmacol 8 2 (2008) 330-340
18. Bose A., and Baral R. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12. Human Immunol 68 10 (2007) 823-831
19. Bose A., Haque E., and Baral R. Neem leaf preparation induces apoptosis of tumor cells by releasing cytotoxic cytokines from human peripheral blood mononuclear cells. Phytother Res 21 10 (2007) 914-920
20. Hodge J.W. Carcinoembryonic antigen as a target for cancer vaccines. Cancer Immunol Immunother 43 3 (1996) 127-134
21. Dalerba P., Maccalli C., Casati C., Castelli C., and Parmiani G. Immunology and immunotherapy of colorectal cancer. Crit Rev Oncol Hematol 46 1 (2003) 33-57
22. Muraro R., Wunderlich D., and Thor A. Definition by monoclonal antibodies of repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res 45 11 (1985) 5769-5780
23. Vincent R.G., Chu T.M., Lane W.W., Gutierrez A.C., Stegemann P.J., and Madajewicz S.J. Carcinoembryonic antigen as a monitor of successful surgical resection in 130 patients with carcinoma of the lung. J Thorac Cardiovasc Surg 75 5 (1978) 734-739
24. Steward A.M., Nixon D., Zamcheck N., and Aisenberg A. Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer (Phila. ) 33 5 (1974) 1246-1252
25. Baral R.N., Saha A., Chatterjee S.K., Foon K.A., Krieg A.M., Weiner G.J., et al. Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen. Cancer Immunol Immunother 52 5 (2003) 317-327
26. Hörig H., Wainstein A., Long L., Kahn D., Soni S., Marcus A., et al. A new mouse model for evaluating the immunotherapy of human colorectal cancer. Cancer Res 61 23 (2001) 8520-8526
27. Bhattacharya-Chatterjee M., Baral R.N., Chatterjee S.K., Das R., Zeytin H., Chakraborty M., et al. Counterpoint: cancer vaccine: single epitope anti-idiotype vaccine versus multiple epitope antigen vaccine. Cancer Immunol Immunother 49 (2000) 133-141
28. Brossart P., Wirths S., Brugger W., and Kanz L. Dendritic cells in cancer vaccines. Exp Hematol 29 11 (2001) 1247-1255
29. Makala L.H.C., Nishikawa Y., Kamada T., Xuan X., and Nagasawa H. Antigen presentation by murine peritoneal cavity macrophage-derived dendritic cells. Pathobiology 69 2 (2001) 104-112
30. Bailey J.L. Miscellaneous analytical methods. In: Bailey J.L. (Ed). Techniques in protein chemistry (1967), Elsevier, New York 340-346
31. Baral R., and Maity P. Induction of colorectal cancer in rats by 20-methylcholanthrene. Cancer Lett 61 2 (1992) 177-183
32. Pennline K.J. Adherence to plastic or glass surfaces. In: Herscowitz H.B., Holden H.T., Bellanti J.A., and Ghaffer A. (Eds). Manual of macrophage methodology: collection, characteristics and function (1981), Marcel Dekker Inc., New York 63-68
33. Yam L.T., Li C.Y., and Crosby W.H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55 3 (1971) 283-290
34. Haworth R., Platt N., Keshav S., Hughes D., Darley E., Suzuki H., et al. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med 186 9 (1997) 1431-1439
35. Sarkar K., Bose A., Laskar S., Choudhuri S.K., Dey S., Roychowdhury P.K., et al. Antibody response against neem leaf preparation recognizes carcinoembryonic antigen. Int Immunopharmacol 7 3 (2007) 306-312
36. Bose A., Ghosh D., Pal S., Mukherjee K.K., Biswas J., and Baral R. Interferon alpha2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling. Oral Oncol 42 2 (2006) 161-171
37. Saha A., Chatterjee S.K., Foon K.A., Primus F.J., Sreedharan S., Mohanty K., et al. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. Cancer Res 64 14 (2004) 4995-5003
38. 2+ mobilization. J Exp Med 186 11 (1997) 1897-1910
39. Dinkel A., Aicher W.K., Haas C., Zipfel P.E., Peter H.H., and Eibel H. Transcription factor Egr-1 activity down-regulates Fas and CD23 expression in B cells. J Immunol 159 6 (1997) 2678-2684
40. Barker J., and Verfaillie C.M. A novel in vitro model of early human adult B lymphopoiesis that allows proliferation of pro-B cells and differentiation to mature B lymphocytes. Leukemia 14 9 (2000) 1614-1620
41. Sánchez-Mejorada G., and Rosales C. Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol 63 5 (1998) 521-533
42. Collins J.T., and Dunnick W.A. Germline transcript of the murine immunoglobulin gamma 2a gene: structure and induction by IFNγ. Int Immunol 5 8 (1993) 885-891
43. Hayes M.P., Freeman S.L., and Donnelly R.P. IFN-γ priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and mRNA stability. Cytokine 7 5 (1994) 427-435
44. Haque E., Mandal I., Pal S., and Baral R. Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory. Immunopharmacol Immunotoxicol 28 1 (2006) 1-18